Interaction between Azathioprine and Mercaptopurine
Major
Synergy
| ID | DDInter150 and DDInter1156 |
| Interaction |
Azathioprine may potentiate the toxicities of 6-mercaptopurine. Azathioprine is metabolized to 6-mercaptopurine in vivo, thus concomitant administration may result in additive adverse effects, including myelosuppression, immunosuppression, and hepatotoxicity.
abortion spontaneous
Acidosis
amenorrhea
Anorexia
Aching joints
arthritis
Arthritis rheumatoid
AFIB
Bacterial infection
Clotting
More
|
| Management | Concurrent use of azathioprine and 6-mercaptopurine should be avoided. |
| References | |
| Alternative for Azathioprine |
L04A
More
|
| Alternative for Mercaptopurine |
L01B
R03D |
Potential Metabolism Interactions
Substrate-Substrate Interaction:If more than one drug is metabolized by the same CYP, it is possible that its metabolism is inhibited because of the competition between the drugs. That means, it can be useful to lower the dosage of the drugs in the drug-cocktail because they remain longer in the organism than in monotherapy.
Inhibitor-Inhibitor Interaction:Combining two or more inhibitors of one CYP, should be compensated by lowering the dosage of these drugs because the metabolism is reduced and the drugs remain longer in the organism than in monotherapy. Not adapting the dosage bears the risk of even more side effects.
Inhibitor-Substrate Interaction:Combining drugs that have inhibitory effect and are substrates of one particular CYP, should be compensated by lowering the dosage. They rest longer in the organism than in monotherapy. Not adapting the dosage bears the risk of even more side effects.